Education
About Us
Working with TipRanks
Follow Us
TherapeuticsMD (TXMD)
NASDAQ:TXMD
Total Valuation
TherapeuticsMD has a market cap or net worth of $12.38M. The enterprise value is $13.96M.
Market Cap$12.38M
Enterprise Value$13.96M
Share Statistics
TherapeuticsMD has 11,574,362 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding11,574,362
Owned by Insiders1.48%
Owned by Institutions21.07%
Financial Efficiency
TherapeuticsMD’s return on equity (ROE) is -0.08 and return on invested capital (ROIC) is -12.72%.
Return on Equity (ROE)-0.08
Return on Assets (ROA)-0.06
Return on Invested Capital (ROIC)-12.72%
Return on Capital Employed (ROCE)-0.14
Revenue Per Employee1.76M
Profits Per Employee-2.18M
Employee Count1
Asset Turnover0.05
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of TherapeuticsMD is ―. TherapeuticsMD’s PEG ratio is 0.07.
PE Ratio―
PS Ratio5.63
PB Ratio0.36
Price to Fair Value0.36
Price to FCF8.48
Price to Operating Cash Flow9.29
PEG Ratio0.07
Income Statement
In the last 12 months, TherapeuticsMD had revenue of 1.76M and earned -2.18M in profits. Earnings per share was -0.19.
Revenue1.76M
Gross Profit1.76M
Operating Income-4.76M
Pretax Income-2.34M
Net Income-2.18M
EBITDA-2.98M
Earnings Per Share (EPS)-0.19
Cash Flow
In the last 12 months, operating cash flow was 1.34M and capital expenditures 0.00, giving a free cash flow of 1.03M billion.
Operating Cash Flow1.34M
Free Cash Flow1.03M
Free Cash Flow per Share0.09
Dividends & Yields
TherapeuticsMD pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.60
52-Week Price Change-35.54%
50-Day Moving Average1.11
200-Day Moving Average1.11
Relative Strength Index (RSI)44.55
Average Volume (3m)16.51K
Important Dates
TherapeuticsMD upcoming earnings date is Nov 17, 2025, Before Open (Confirmed).
Last Earnings DateAug 12, 2025
Next Earnings DateNov 17, 2025
Ex-Dividend Date―
Financial Position
TherapeuticsMD as a current ratio of 2.37, with Debt / Equity ratio of 20.95%
Current Ratio2.37
Quick Ratio2.37
Debt to Market Cap0.16
Net Debt to EBITDA-0.71
Interest Coverage Ratio-501.05
Taxes
In the past 12 months, TherapeuticsMD has paid -31.00K in taxes.
Income Tax-31.00K
Effective Tax Rate0.01
Enterprise Valuation
TherapeuticsMD EV to EBITDA ratio is -4.03, with an EV/FCF ratio of 10.29.
EV to Sales6.83
EV to EBITDA-4.03
EV to Free Cash Flow10.29
EV to Operating Cash Flow10.29
Balance Sheet
TherapeuticsMD has $6.07M in cash and marketable securities with $5.72M in debt, giving a net cash position of $351.00K billion.
Cash & Marketable Securities$6.07M
Total Debt$5.72M
Net Cash$351.00K
Net Cash Per Share$0.03
Tangible Book Value Per Share$2.00
Margins
Gross margin is 92.34%, with operating margin of -270.30%, and net profit margin of -123.85%.
Gross Margin92.34%
Operating Margin-270.30%
Pretax Margin-133.05%
Net Profit Margin-123.85%
EBITDA Margin-169.39%
EBIT Margin-198.30%
Analyst Forecast
The average price target for TherapeuticsMD is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast156.93%
EPS Growth Forecast92.75%